EHA 2019 | NKG2D CARs for R/R AML and MDS

David Sallman

David Sallman, MD, Moffitt Cancer Center, Tampa, FL, discusses the use of NKG2D CARs for relapsed/refractory acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

Share this video  
Similar topics